Lotus Pharmaceuticals, Inc.
7900 Glades Road
Suite 420
Boca Raton
Florida
33434
United States
Tel: 954-208-0154
Fax: 561-988-9890
Website: http://www.lotuseast.com/
Email: info@LotusEast.com
84 articles about Lotus Pharmaceuticals, Inc.
-
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces Advance of $5 Million Milestone Payment from Partners Alvogen, Inc. and Lotus Pharmaceutical Co. Ltd. (1975.TW)
2/12/2024
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced the advance of the first $5 million milestone payment based on the Company's partnership agreement with Alvogen, Inc. and Lotus Pharmaceutical Co. Ltd. (1975.TW).
-
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Reports Comments by Strategic Partner Lotus Pharmaceutical Co. Ltd. (1975.TW) in Recent Financial Report
2/9/2024
NRx Pharmaceuticals, Inc. today announced that its Asia Pacific strategic partner Lotus Pharmaceutical Co. Ltd (1975.TW) identified enrollment completion of the NRx clinical trial in bipolar depression as a material event in is February 7 financial filing.
-
Corium and Lotus Pharmaceutical Enter into Exclusive License Agreement for Innovative Alzheimer's Disease Treatment ADLARITY® in Multiple Markets Across Asia
8/10/2023
Corium, LLC and Lotus Pharmaceutical announced that the companies have entered into an exclusive Collaboration and License Agreement for ADLARITY®, an innovative Alzheimer’s dementia treatment, in ten markets across Asia.
-
Amarin and Lotus Pharmaceuticals Announce Exclusive Partnership Agreement to Commercialize Vazkepa® (Icosapent Ethyl) in Southeast Asia and South Korea
7/31/2023
Amarin Corporation plc and Lotus Pharmaceuticals announced that the two companies have entered into a long-term exclusive partnership to distribute and commercialize VAZKEPA® across 10 countries, including nine in Southeast Asia and South Korea.
-
NRx Pharmaceuticals, Lotus Pharmaceuticals and Alvogen Inc. Announce Collaboration to Develop and Commercialize NRX-101
6/5/2023
Lotus Pharmaceuticals (1795:TT; “Lotus”) and NRx Pharmaceuticals Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals or NRx”), a clinical stage biopharmaceutical company, today announced a global collaboration agreement covering the development and commercialization of NRX-101 for suicidal treatment-resistant bipolar depression (S-TRBD) for global markets.
-
Lotus Reports Its Best Quarter Ever With the Biggest Launch in Its History
11/11/2022
Lotus Pharmaceutical, a multinational pharmaceutical company, reported its financial results for the third quarter ended 30 September 2022.
-
Lotus Looking at Land Development
5/6/2021
Lotus Pharmaceuticals, Inc President Georgene Rivers announced that Lotus Pharmaceuticals, Inc. has entered into a Land Development Deal.
-
PTT Invests in Lotus Pharmaceutical's Strategic Partnership in South East Asia
4/19/2021
Lotus Pharmaceutical Co., Ltd. (“Lotus” or “the Company”, Taiwan TWSE ticker: 1795), an Alvogen company, has announced the issuance of new shares through private placement
-
Lotus Pharmaceuticals, Inc. Current with OTC MARKETS
3/17/2021
Lotus Pharmaceuticals, Inc (Pink Sheets: LTUS) President Georgene Rivers announced today that Lotus Pharmaceuticals, Inc. has become current with OTC MARKETS
-
Alvogen and Lotus Announce First to Launch Generic Version of Navelbine® Softgel Capsule in Europe
8/1/2019
Alvogen announced that its subsidiary Lotus Pharmaceuticals has launched Vinorelbine 20, 30 and 80mg soft capsules in Europe.
-
Alvogen And Lotus Pharmaceuticals, Inc. Merge Asian Operations To Create Compelling Platform For International Growth
1/16/2014
-
Lotus Pharmaceuticals, Inc. Filed Its Abbreviated New Drug Application (ANDA) Containing a Paragraph IV Certification for a Generic Version of Xenical(R) With the U.S. Lotus Pharmaceuticals, Inc.
12/11/2012
-
Lotus Pharmaceuticals, Inc. Runs Out of Cash
4/11/2012
-
Public Announcement From Lotus Pharmaceuticals, Inc.
4/10/2012
-
Lotus Pharmaceuticals, Inc. Announces Business Reorganization and Provides Updates on the Beijing Headquarters Building
1/5/2012
-
Lotus Pharmaceuticals, Inc. Announces Third Quarter 2011 Financial Results
11/11/2011
-
Lotus Pharmaceuticals, Inc. Announces Second Quarter Fiscal 2011 Financial Results
8/15/2011
-
Lotus Pharmaceuticals, Inc. Announces First Quarter Fiscal 2011 Financial Results
5/16/2011
-
Lotus Pharmaceuticals, Inc. Responds to Investor Concerns in Exclusive Interview
4/25/2011
-
Lotus Pharmaceuticals, Inc. Announces Fiscal 2010 Financial Results
3/29/2011